[1]
Tan, S.N., Ibrahim, A., Abdul Razak, M.R., Abdul Azih, M.N. and How, S.H. 2023. Intermittent EGFR-TKI Therapy is Associated with Durable Response in Advanced EGFR-Mutant NSCLC: A Case Report. Malaysian Journal of Medicine and Health Sciences. 19, 2 (Mar. 2023), 341–343. DOI:https://doi.org/10.47836/mjmhs.19.2.48.